Compass Pathways Akcija

Compass Pathways ROA

Vrijednost ROA (Povraćaj na imovinu) od Compass Pathways (CMPS) na dan 27. јул 2026. je -136,85 %. Prethodne godine, ROA (Povraćaj na imovinu) je bio -72,60 % — promjena od 88,50% (niži).

ROA

-136,85 %

YoY

88,50%

Zadnja ažuriranja:

U godini 2026 rentabilnost celokupne imovine (ROA) kompanije Compass Pathways iznosila je -136,85 %, što je povećanje za 88,50% u odnosu na -72,60 % ROA prethodne godine.
Access this data via the Eulerpool API

Compass Pathways Анализа акција

Šta radi Compass Pathways? Compass Pathways PLC is a leading company specializing in the development of groundbreaking therapies for the treatment of mental illnesses. The company was founded in 2016 and is headquartered in London. Its goal is to revolutionize the treatment of depression and other mental illnesses. The business model of Compass Pathways is based on researching psychedelics as a potential treatment for patients suffering from severe depression and anxiety disorders. The company uses innovative approaches to precisely study the effects of psychedelics on the human brain and develop new therapy concepts and products from that. An important area of Compass Pathways is clinical research. The company collaborates closely with leading research institutions to understand the impacts of psychedelics on the human brain. The research results are then used to develop innovative methods for therapeutic use of psychedelics. Another important area of Compass Pathways is the development of therapeutic products. The company has developed a patented process for producing psilocybin, a substance found in hallucinogenic mushrooms. This process achieves a very high purity of the substance, enabling precise dosing and better control of its effects. The flagship product of Compass Pathways is COMP360, a medication based on psilocybin that is being developed for the treatment of depression. The medication is currently in clinical Phase 2 trials, showing promising results. If COMP360 receives approval, it has the potential to drastically change the way we treat depression. Compass Pathways is also active in other areas. The company conducts a range of research projects related to various psychedelic substances, including LSD and other hallucinogens. Another important area of Compass Pathways is training therapists and other professionals in the use of psychedelic substances. The company offers relevant courses to promote understanding of the therapeutic use of psychedelics and enable their safe and effective application for patient treatment. Overall, Compass Pathways is a company focused on the development of groundbreaking therapies for mental illnesses. Through combining cutting-edge research, innovative products, and professional education, the company has the potential to revolutionize the way we treat mental illnesses. Compass Pathways je jedna od najpopularnijih kompanija na Eulerpool.

ROA у детаљу

Razumevanje rentabilnosti kapitala (ROA) od Compass Pathways

Rentabilnost kapitala (ROA) od Compass Pathways je ključni pokazatelj koji meri profitabilnost preduzeća u odnosu na ukupnu imovinu. Izračunava se deljenjem neto dobitka sa ukupnom imovinom. Viša ROA ukazuje na efikasniju upotrebu imovine za stvaranje profita i odražava efikasnost upravljanja i finansijsko zdravlje.

Poređenje godina za godinom

Upoređivanje ROA od Compass Pathways iz godine u godinu pruža uvid u operativnu efikasnost i trendove u korišćenju imovine preduzeća. Rastuća ROA ukazuje na poboljšanu efikasnost imovine i profitabilnost, dok smanjenje ROA može ukazivati na operativne ili finansijske izazove.

Utjecaj na investicije

Investitori smatraju ROA od Compass Pathways ključnom metrikom za ocenu profitabilnosti i efikasnosti preduzeća. Veća ROA znači da preduzeće efikasno koristi svoju imovinu za stvaranje profita, što ga čini potencijalno privlačnom investicijom.

Tumačenje fluktuacija ROA

Fluktuacije u ROA od Compass Pathways mogu biti posledica promena u neto dobiti, sticanju imovine ili operativnoj efikasnosti. Analiza ovih fluktuacija pomaže u ocenjivanju finansijskog učinka, efikasnosti upravljanja i strateškog pozicioniranja finansija preduzeća.

Često postavljena pitanja o akciji Compass Pathways

ROA (Povraćaj na imovinu) kompanije Compass Pathways iznosi -136,85 % u 2026. godini.

Access this data via the Eulerpool API

Профитабилност — Compass Pathways

Sve ključne metrike — Compass Pathways

Раст